Literature DB >> 7753061

Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease.

E D Louis1, J E Goldman, J M Powers, S Fahn.   

Abstract

Premortem diagnosis of diffuse Lewy body disease (DLBD) is difficult, and knowledge of the parkinsonian features of DLBD might facilitate the diagnosis. In this study, we compared the parkinsonian syndrome of DLBD and Parkinson's disease (PD). We retrospectively reviewed the charts of Columbia-Presbyterian Medical Center (CPMC) Brain Bank cases (1989-1993) with pathologically diagnosed DLBD or PD, and the literature on the parkinsonian features in DLBD patients presenting with parkinsonism. Parkinsonism accompanied or preceded cognitive/psychiatric changes in most CPMC cases (DLBD 100%, PD 88%). DLBD had an earlier mean age of onset than PD did (57 versus 64 years), a similar male:female ratio (1.7:1 versus 1.9:1), and similar mean disease duration (12-13 years). Cognitive/psychiatric changes were less frequent in PD than in DLBD (65 versus 100%) (p = 0.025). Rest tremor was specifically mentioned in 29% of DLBD versus 56% of PD (p = 0.10). Bradykinesia was less common in PD (56% versus 86%) (p = 0.05). All those with PD responded to L-Dopa, as did all those with DLBD who received L-Dopa. In conclusion, there are subtle differences between PD and DLBD in age of onset, frequency of cognitive/psychiatric changes, bradykinesia, and rest tremor. However, even when taken together, these cannot be used to distinguish these entities.

Entities:  

Mesh:

Year:  1995        PMID: 7753061     DOI: 10.1002/mds.870100209

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

1.  Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease.

Authors:  M A Hely; W G Reid; G M Halliday; D A McRitchie; J Leicester; R Joffe; W Brooks; G A Broe; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.

Authors:  K K Gnanalingham; E J Byrne; A Thornton; M A Sambrook; P Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 3.  Diffuse Lewy body disease: clinical, pathological, and neuropsychological review.

Authors:  C A Luis; W Mittenberg; C S Gass; R Duara
Journal:  Neuropsychol Rev       Date:  1999-09       Impact factor: 7.444

4.  Diffuse Lewy Body Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Peter B. Dunne; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

Review 5.  Lewy body dementia.

Authors:  J Byrne
Journal:  J R Soc Med       Date:  1997       Impact factor: 18.000

6.  The role of levodopa in the management of dementia with Lewy bodies.

Authors:  S Molloy; I G McKeith; J T O'Brien; D J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

Review 7.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

Review 8.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 9.  Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.

Authors:  David G Coughlin; Howard I Hurtig; David J Irwin
Journal:  Mov Disord       Date:  2019-10-29       Impact factor: 10.338

Review 10.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.